[1] For people with type 2 diabetes who are taking insulin or sulfonylureas alongside Wegovy, hypoglycaemia (low blood sugar) is another potential cause of fatigue that requires careful monitoring
Your skin will feel softer, calmer, and more resilient, revealing a balanced and glowing complexion
It also activates lipolysis (fat breakdown), increases thermogenesis (burning energy as heat), and overall raises the bodys energy expenditure
Tirzepatide typically requires 1216 weeks or longer to produce meaningful weight loss and glycemic improvements, particularly as doses are gradually escalated every 4 weeks from the starting 2.5 mg to therapeutic maintenance levels of 1015 mg weekly
Some people need consistent dosing
Cardiovascular outcomes trials demonstrate favourable safety profiles with some agents reducing major adverse cardiovascular events